Murono, Koji
Nagata, Hiroshi
Ishimaru, Kazuhiro
Emoto, Shigenobu
Kaneko, Manabu
Hiyoshi, Masaya
Sasaki, Kazuhito
Otani, Kensuke
Shuno, Yasutaka
Nishikawa, Takeshi
Tanaka, Toshiaki
Hata, Keisuke
Kawai, Kazushige
Nozawa, Hiroaki
Muro, Kei
Ishihara, Soichiro
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (16K07143, 16K07161, 17K10620, 17K10621, 17K10623, 18K07194)
Japan Agency for Medical Research and Development (18cm0106502h0003)
Article History
Received: 18 August 2018
Accepted: 25 October 2018
First Online: 1 November 2018
Compliance with ethical standards
:
: K. Muro is on the advisory board meeting for Bristol-Myers Squibb and Nippon Kayaku Co, Ltd. All remaining authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of the University of Tokyo (P2015038-11X) and with the 1964 Helsinki declaration and its later amendments. The study was registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR) (UNIN000022924).
: Written informed consent was obtained from all individual participants included in the study.